Analysts Set Arteris, Inc. (NASDAQ:AIP) Target Price at $17.50

Shares of Arteris, Inc. (NASDAQ:AIPGet Free Report) have been given a consensus rating of “Moderate Buy” by the six analysts that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $17.50.

A number of equities research analysts have recently weighed in on AIP shares. TD Cowen boosted their price target on Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a report on Wednesday, November 5th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Arteris in a report on Monday, December 15th. Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, October 8th. Finally, Cowen reaffirmed a “buy” rating on shares of Arteris in a report on Wednesday, November 5th.

Check Out Our Latest Analysis on Arteris

Insider Buying and Selling at Arteris

In related news, COO Laurent R. Moll sold 32,775 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $15.42, for a total transaction of $505,390.50. Following the completion of the transaction, the chief operating officer directly owned 311,110 shares in the company, valued at $4,797,316.20. This represents a 9.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO K Charles Janac sold 70,000 shares of the stock in a transaction on Monday, December 8th. The stock was sold at an average price of $17.71, for a total value of $1,239,700.00. Following the completion of the sale, the chief executive officer directly owned 9,469,071 shares in the company, valued at $167,697,247.41. This represents a 0.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 586,079 shares of company stock worth $9,861,292 over the last ninety days. Company insiders own 29.10% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Westerly Capital Management LLC lifted its holdings in Arteris by 109.6% in the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after purchasing an additional 745,000 shares during the period. Granahan Investment Management LLC raised its position in shares of Arteris by 725.7% during the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after buying an additional 546,341 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Arteris in the 1st quarter worth approximately $1,621,000. Roubaix Capital LLC acquired a new stake in shares of Arteris in the 3rd quarter worth approximately $2,361,000. Finally, Algert Global LLC bought a new position in shares of Arteris in the third quarter valued at approximately $2,250,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Arteris Stock Performance

Shares of Arteris stock opened at $17.37 on Tuesday. Arteris has a 1 year low of $5.46 and a 1 year high of $19.85. The firm’s 50-day simple moving average is $15.68 and its 200-day simple moving average is $12.36. The firm has a market cap of $758.72 million, a PE ratio of -20.93 and a beta of 1.48.

Arteris (NASDAQ:AIPGet Free Report) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The firm had revenue of $17.41 million during the quarter, compared to analyst estimates of $17.00 million. On average, equities analysts predict that Arteris will post -0.73 earnings per share for the current year.

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Recommended Stories

Analyst Recommendations for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.